Submission of Notice of 32nd Annual General meeting for the Finanical Year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Ltd has submitted the notice of its 32nd Annual General Meeting for the financial year 2024-25 to BSE, in compliance with SEBI LODR Regulation 34. The AGM is scheduled for Friday, 19th September 2025 at 3:00 PM and will be held via Video Conference / Other Audio-Visual Means. The annual report along with the notice was dispatched to shareholders on 28th August 2025. A web link to the annual report has also been placed on the company's website (www.oxygentapharma.com) for members who have not registered their email addresses. The filing was signed by Balasubba Reddy Mamilla, Executive Director.
This is a routine regulatory compliance filing and has no direct material impact on the stock. Shareholders should review the AGM notice and annual report for details on financial results, dividend, director appointments, and other items up for voting at the meeting on 19th September 2025.